Corona Vaccine Funded by Bill Gates

Inovio’s candidate, called INO-4800, is the second potential coronavirus vaccine to start human trials in the US. The Massachusetts biotech Moderna started dosing in mid-March for its own safety trial. 

It’s production capabilities is aiming to have 1 million doses available by the end of 2020. These doses could be used in additional clinical trials or emergency use, if required.

See the source image



Facebook Comments